Evidence map›Paper›PMID 42262458›Full record

ReviewTopics in current chemistry (Cham)2026

Multicomponent Reactions for the Synthesis of Oxazepines.

Hassan Farhid, Mojtaba Mahyari, Abbas Abdolmaleki, Yasser Mohammadi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Topics in current chemistry (Cham), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hassan FarhidDepartment of Organic Chemistry, Shahid Beheshti University, G.C., P.O. Box 19396-4716, Tehran, Iran.
Mojtaba MahyariFaculty of Chemistry and Chemical Engineering, Malek Ashtar University of Technology, P.O. Box 16765-3454, Tehran, Iran. mo.mahyari@gmail.com.
Abbas AbdolmalekiFaculty of Chemistry and Chemical Engineering, Malek Ashtar University of Technology, P.O. Box 16765-3454, Tehran, Iran.
Yasser MohammadiOrganic Polymer Chemistry Research Laboratory, Department of Chemistry, Faculty of Science, Arak University, Arak, 38156-8-8349, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxazepines are seven-membered heterocyclic frames containing oxygen and nitrogen within their structure and are regarded as privileged scaffolds in medicinal chemistry. These structures constitute the parent core of several essential drugs and have numerous biological properties like antifungal, anti-inflammatory, antibacterial, antitumor, anti-HIV, and antidepressant activities. The wide biological activities of oxazepines have encouraged organic chemists to design various novel synthetic routes to synthesize new oxazepine derivatives. Though undoubtedly valuable and significant, many of these synthetic methods often involve multistep procedures that suffer from the waste generation of materials. In contrast, multicomponent reactions (MCRs) have recently emerged as sustainable synthetic tools for the synthesis of various types of oxazepines. In this regard, MCRs, especially Ugi and Betti reactions, can provide complex synthons in a straightforward and green manner for the synthesis of oxazepine derivatives. MCRs can also produce oxazepines in high yields in a single pot and a single step. The present review covers articles on the synthesis of oxazepines via MCRs from their inception to 2025. It will be beneficial for chemists to design safe, economical, and environmentally benign methods for the synthesis of diverse types of oxazepines.

Indexed as

OxazepinesMolecular StructureOxazepinesBetti reactionHeterocyclesIsocyanidesMulticomponent reactionsOxazepinesUgi reaction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.